Microbot Medical Inc (NASDAQ:MBOT) Director Yoseph Bornstein sold 42,132 shares of the stock in a transaction that occurred on Tuesday, January 2nd. The stock was sold at an average price of $1.01, for a total value of $42,553.32. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Yoseph Bornstein also recently made the following trade(s):

  • On Wednesday, December 27th, Yoseph Bornstein sold 14,257 shares of Microbot Medical stock. The stock was sold at an average price of $1.02, for a total value of $14,542.14.
  • On Tuesday, December 19th, Yoseph Bornstein sold 32,067 shares of Microbot Medical stock. The stock was sold at an average price of $1.03, for a total value of $33,029.01.
  • On Tuesday, December 12th, Yoseph Bornstein sold 44,159 shares of Microbot Medical stock. The stock was sold at an average price of $1.04, for a total value of $45,925.36.
  • On Wednesday, December 6th, Yoseph Bornstein sold 15,375 shares of Microbot Medical stock. The shares were sold at an average price of $1.05, for a total value of $16,143.75.
  • On Tuesday, November 21st, Yoseph Bornstein sold 45,000 shares of Microbot Medical stock. The shares were sold at an average price of $1.21, for a total value of $54,450.00.
  • On Tuesday, November 28th, Yoseph Bornstein sold 45,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.07, for a total value of $48,150.00.
  • On Tuesday, October 24th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.14, for a total value of $57,000.00.
  • On Tuesday, October 17th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.16, for a total value of $58,000.00.
  • On Tuesday, October 10th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.38, for a total value of $69,000.00.
  • On Thursday, October 5th, Yoseph Bornstein sold 22,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.49, for a total value of $32,780.00.

Shares of Microbot Medical Inc (NASDAQ:MBOT) traded down $0.01 during trading on Wednesday, reaching $1.01. The company had a trading volume of 664,600 shares, compared to its average volume of 598,650. Microbot Medical Inc has a 52-week low of $1.00 and a 52-week high of $9.94. The firm has a market capitalization of $41.54, a PE ratio of -1.46 and a beta of -0.41.

A hedge fund recently raised its stake in Microbot Medical stock. Vanguard Group Inc. lifted its holdings in shares of Microbot Medical Inc (NASDAQ:MBOT) by 252.2% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 159,992 shares of the biotechnology company’s stock after acquiring an additional 114,561 shares during the quarter. Vanguard Group Inc. owned 0.43% of Microbot Medical worth $228,000 as of its most recent filing with the SEC. 4.66% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: This report was first posted by American Banking News and is the property of of American Banking News. If you are reading this report on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The original version of this report can be read at https://www.americanbankingnews.com/2018/01/03/yoseph-bornstein-sells-42132-shares-of-microbot-medical-inc-mbot-stock.html.

Microbot Medical Company Profile

Microbot Medical Inc, formerly StemCells, Inc, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures.

Insider Buying and Selling by Quarter for Microbot Medical (NASDAQ:MBOT)

Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.